METROPOLITAN LIFE INSURANCE CO/NY - BROOKLYN IMMUNOTHERAPEUTICS ownership

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2021$80,082
-46.2%
8,611
+4.1%
0.00%
-50.0%
Q2 2021$148,9798,2720.00%
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
LAKE STREET ADVISORS GROUP, LLC 2,446,417$604,0000.04%
INVERNESS COUNSEL LLC /NY/ 1,210,537$299,0000.02%
Sippican Capital Advisors 37,500$9,0000.01%
ARMISTICE CAPITAL, LLC 1,109,807$274,0000.01%
Virtu Financial LLC 63,122$16,0000.00%
Renaissance Technologies 1,459,626$360,0000.00%
Allegheny Financial Group LTD 11,595$2,0000.00%
AJ WEALTH STRATEGIES, LLC 36,001$9,0000.00%
BALDWIN BROTHERS LLC/MA 40,604$10,0000.00%
FMR LLC 36$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders